[1] 高娟, 李志红, 安宇亮, 郭力, GAO Juan, LI Zhi-Hong, AN Yu-Liang, GUO Li. 青年心脑血管疾病患者同型半胱氨酸水平及干预研究 [J]. 军医进修学院学报 2008.doi:10.3969/j.issn.1005-1139.2008.01.005
[2] Bathum, L, Petersen, I, Christiansen, L, Konieczna, A, Sorensen, TI, Kyvik, KO. Genetic and environmental influences on plasma homocysteine: results from a Danish twin study. [J]. Clinical Chemistry 2007, 5(5).
[3] Frosst P, Blom H J, Milos R. A candidate genetic risk factor for vascular disease:a common mutation in methylene-tetrahydrofolate reductase [J]. Nature Genetics 1995, 10(01).
[4] Harkery L A, Slichter S T, Scott C R. Homocysteinemia vascular injury and arterial thrombosis [J]. New England Journal of Medicine 1974, 291(04).
[5] 闵姜勇, 叶怀莲, 李昌棣. 胱氨酸致家兔动脉粥样硬化的实验研究 [J]. 1994.
[6] Stampfer M J, Malinow M R, Willett W C. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians [J]. Journal of the American Medical Association 1992, 268(07).
[7] Boushey C J, Beresford S A, Omcnn G S. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease [J]. Journal of the American Medical Association 2003, 274(13).
[8] Clarke R, Daly L, Robinson K. Hyperhomocysteinemia:an independent factor for vascular diease [J]. New England Journal of Medicine 1991, 324(17).
[9] Bos MJ, van Goor ML, Koudstaal PJ, Dippel DW. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. [J]. Journal of neurology 2005, 3(3).
[10] 王胜慧. 对高同型半胱氨酸血症与缺血性脑血管病相关性的研究 [J]. 中国医学文摘-内科学分册 2006, 3(20).
[11] Jacob S, Paul F, Andrew G. Association between plasma homocysteine consentrations and extrecrantal Carotid-arterystenosis [J]. New England Journal of Medicine 1995, 32(02).
[12] Selhub J, Jacques P F, Bostom A G. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis [J]. New England Journal of Medicine 2005, 332(05).
[13] Pezzini A, Del Zotto E, Archetti S, Negrini R, Bani P, Albertini A, Grassi M, Assanelli D, Gasparotti R, Vignolo LA, Magoni M, Padovani A. Plasma homocysteine concentration, C677T MTHFR genotype, and 844ins68bp CBS genotype in young adults with spontaneous cervical artery dissection and atherothrombotic stroke. [J]. Stroke: A Journal of Cerebral Circulation 2002, 3(3).
[14] Den Heijer M, Kostor T, Blom H J. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis [J]. New England Journal of Medicine 1996, 334(07).
[15] Ridker P M, Hennekens C H, Selhub J. Interrelation of hyperhomocyst(e)inemia.factor V Leiden and risk of future venous thromboembolism [J]. Circulation 2003, 95(07).
[16] Ottar Nygard, Stein Emil, Helga Refsum. Total plasma homocysteine and cardiovascular risk profile [J]. Journal of the American Medical Association 1995, 274(19).
[17] Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, Lentz SR. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. [J]. Stroke: A Journal of Cerebral Circulation 2004, 8(8).
[18] Tsai M Y, Grag U, Key N S. Molecular and biochemical approaches in the identification of heterozgotes for homocysteinuria [J]. Atheroclerosis 1996, 122(01).
[19] Fohr IP, Prinz-Langenohl R, Bronstrup A, Bohlmann AM, Nau H, Berthold. 5, 10-methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women [J]. The American Journal of Clinical Nutrition: Official Journal of the American Society for Clinical Nutrition 2002, 2(2). |
